A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Danielle Duffy, MD
CSL Behring
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Study Site 17001
Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Study Site 17014
Frankfurt am Main, Hesse, Germany
- Study Site 17003
Berlin, Germany
- Study Site 17005
Berlin, Germany
- Study Site 17009
Berlin, Germany
- Study Site 17006
Hamburg, Germany
- Study Site 18001
Budapest, Hungary
- Study Site 18005
Budapest, Hungary
- Study Site 18007
Nyíregyháza, Hungary
- Study Site 18003
Pécs, Hungary
- Study Site 18009
Szeged, Hungary
- Study Site 19005
Haifa, Israel
- Study Site 19002
Nahariya, Israel
- Study Site 19008
Safed, Israel
- Study Site 21001
Alkmaar, Netherlands
- Study Site 21006
Amsterdam, Netherlands
- Study Site 21017
Amsterfoort, Netherlands
- Study Site 21008
Nijmegen, Netherlands
- Study Site 16101
Birmingham, Alabama, United States
- Study Site 16078
Huntsville, Alabama, United States
- Study Site 16168
Concord, California, United States
- Study Site 16130
Littleton, Colorado, United States
- Study Site 16135
Danbury, Connecticut, United States
- Study Site 16003
Jacksonville, Florida, United States
- Study Site 16112
Boise, Idaho, United States
- Study Site 16208
Alexandria, Louisiana, United States
- Study Site 16061
Petoskey, Michigan, United States
- Study Site 16056
Durham, North Carolina, United States
- Study Site 16014
High Point, North Carolina, United States
- Study Site 16018
Rapid City, South Dakota, United States
- Study Site 16241
Wichita Falls, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2016
- Primary completion
- 30 Jun 2017
- Completion
- 30 Jun 2017
- Last update posted
- 11 Jun 2020
- Registered enrollment
- 83
- Registry id
- NCT02742103
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.